Health Care & Life Sciences » Pharmaceuticals » Johnson & Johnson | Johnson & Johnson top pharmaceutical products 2014-2017

Revenue of Johnson & Johnson's pharmaceutical products 2014-2017

Revenue of Johnson & Johnson's top pharmaceutical products from 2014 to 2017 (Figures expressed in millions of U.S. dollars, unless otherwise specified)

The data displays the global revenue of Johnson & Johnson's pharmaceutical segment from 2014 to 2017, by product. In 2016, Remicade was Johnson & Johnson's leading product, generating seven billion USD in revenue. Johnson & Johnson is a multinational company, specialized on pharmaceuticals, medical devices and consumer goods. The company is headquartered in New Brunswick, New Jersey.

Remicade 6868 6561 6966 6315
Stelara 2072 2474 3232 4011
Invega (Sustenna/Xeplon) 1588 1830 2214 2569
Zytiga 2237 2231 2260 2505
Xarelto 1522 1868 2288 2500
Imbruvica 200 689 1251 1893
Simponi/Simponi Aria 1187 1328 1745 1833
Prezista 1831 1810 1851 1821
Darzalex 20 572 1242
Velcade 1618 1333 1224 1114
Invokana/Invokamet 586 1308 1407 1111

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.